UDA-GS: A cross-center multimodal unsupervised domain adaptation framework for Glioma segmentation.

Journal: Computers in biology and medicine
PMID:

Abstract

Gliomas are the most common and malignant form of primary brain tumors. Accurate segmentation and measurement from MRI are crucial for diagnosis and treatment. Due to the infiltrative growth pattern of gliomas, their labeling is very difficult. In turn, the already available annotated datasets, such as well-known BraTS, are difficult to generalize to multicenter unannotated datasets due to the variations in imaging machines and parameters. To address this challenge, a novel unsupervised domain adaptation framework for glioma segmentation (UDA-GS) is proposed. UDA-GS uses GliomaMix to mix labeled tumors with unlabeled images and aligns the features of the same tumor, allowing the network to adapt to different backgrounds across different centers. Additionally, the framework leverages tumor information generated by GliomaMix as prior knowledge for self-supervised regression tasks to enhance feature encoding for tumors in different domains. Using Mean-Teacher as the basic framework, UDA-GS also incorporates weighted consistency regularization and mask combining strategy to achieve efficient unsupervised domain adaptation. Quantitative and qualitative evaluations were conducted on 1179 cases across 27 centers, without requiring any local annotations. The results demonstrate that UDA-GS outperforms the second-best method in terms of Dice coefficient segmentation metrics by 18.2 %, 6.9 %, and 4.6 % for the whole tumor, tumor core, and enhanced tumor, respectively, on the internal testing set. Additionally, the evaluations reveal that doctors express greater satisfaction with the segmentation outcomes achieved by UDA-GS in comparison to other methods including the segment anything model (SAM).

Authors

  • Zhaoyu Hu
    School of Information Science and Technology, Fudan University, Shanghai, China.
  • Yuhao Sun
    Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan, Shandong250014, China.
  • LiuGuan Bian
    Department of Neurosurgery, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chun Luo
    Department of Neurosurgery, Tongji Hospital, Tongji University, Shanghai, China.
  • Junle Zhu
    Department of Neurosurgery, Tongji Hospital, Tongji University, Shanghai, China.
  • Jin Zhu
    Department of Laboratory, Quzhou People's Hospital, Quzhou, Zhejiang, China, qzhosp@163.com.
  • Shiting Li
    Department of Neurosurgery, Xinhua Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zheng Zhao
    College of Bioinformatics Science and Technology and Bio-Pharmaceutical Key Laboratory of Heilongjiang Province, Harbin Medical University, Nangang, Harbin, Heilongjiang, China.
  • Yuanyuan Wang
    Department of Biotechnology, College of Life Science and Technology, Jinan University Guangzhou, 510632, China.
  • Huidong Shi
    Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhifeng Shi
    Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Jinhua Yu
    Department of Electronic Engineering, Fudan University, Shanghai, 200433, China. jhyu@fudan.edu.cn.